BFM
GILD icon

Boothbay Fund Management’s Gilead Sciences GILD Stock Holding History

Boothbay Fund Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,700
Closed -$228K – 2152
2022
Q3 		$228K Buy
+3,700
New +$233K 0.01% 1726
2022
Q2 		– Sell
-28,400
Closed -$1.69M – 2401
2022
Q1 		$1.69M Buy
+28,400
New +$1.82M 0.04% 647
2016
Q4 		– Sell
-6,400
Closed -$506K – 826
2016
Q3 		$506K Buy
+6,400
New +$520K 0.11% 211

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boothbay Fund Management's GILD Position: Q2 2026 in Review

Boothbay Fund Management increased its Gilead Sciences (GILD) stake by 725% in Q2 2026, buying an estimated $3.17M and bringing the position to 27,382 shares worth $3.46M. The position accounts for 0.05% of the portfolio, ranked #465.

Boothbay Fund Management first reported a position in GILD in Q2 2015 and has held it in 22 quarters since. The position peaked at $12.2M in Q1 2023. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Boothbay Fund Management held 27,382 shares of Gilead Sciences worth $3.46M as of Q2 2026.
  • Boothbay Fund Management bought 24,061 Gilead Sciences shares in Q2 2026, an estimated $3.17M.
  • Gilead Sciences made up 0.05% of Boothbay Fund Management's portfolio in Q2 2026, its #465 holding.
  • Boothbay Fund Management first reported a position in Gilead Sciences in Q2 2015 and has held it in 22 quarters since.
  • Boothbay Fund Management's Gilead Sciences position peaked at $12.2M in Q1 2023.
  • 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.